72 phenotypes from 1 allele in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Terctm1Rdp/Terctm1Rdp B6J.Cg-Terctm1Rdp	abnormal adipose tissue distribution	J:213181
	abnormal bone marrow morphology	J:213181
	abnormal bone ossification	J:213181
	abnormal compact bone morphology	J:213181
	abnormal osteoid morphology	J:213181
	abnormal skeleton physiology	J:213181
	decreased bone trabecula number	J:213181
	decreased bone volume	J:213181
	decreased compact bone area	J:213181
	decreased compact bone thickness	J:213181
	decreased trabecular bone thickness	J:213181
	increased bone trabecular spacing	J:213181
	osteoporosis	J:213181
Terctm1Rdp/Terctm1Rdp involves: 129/Sv * C57BL/6 * C57BL/6J * SJL	abnormal cell physiology	J:125218
	abnormal DNA repair	J:125218
	abnormal enterocyte proliferation	J:125218
	abnormal intestine morphology	J:125218
	chromosomal instability	J:125218
	decreased telomere length	J:125218
	increased enterocyte apoptosis	J:125218
	increased lymphoma incidence	J:125218
	premature death	J:125218
Terctm1Rdp/Terctm1Rdp involves: 129/Sv * C57BL/6J * SJL	abnormal angiogenesis	J:74001
	abnormal cardiac muscle contractility	J:110900
	abnormal cardiac muscle relaxation	J:110900
	abnormal cardiovascular system physiology	J:110900
	abnormal chromosome morphology	J:89751
	abnormal developmental patterning	J:53600
	abnormal female meiosis	J:89751
	abnormal fetal cardiomyocyte proliferation	J:110900
	abnormal intestine morphology	J:120065
	abnormal male meiosis	J:89751
	abnormal meiosis	J:89751
	abnormal myocardial fiber morphology	J:110900
	abnormal oocyte morphology	J:89751
	abnormal spermatocyte morphology	J:89751
	abnormal telomere length	J:43517, J:60223, J:74001, J:89751, J:96945, J:110900, J:120065
	alopecia	J:120065
	cardiac hypertrophy	J:110900
	congestive heart failure	J:110900
	decreased B cell proliferation	J:60223
	decreased body size	J:120065
	decreased body weight	J:120065
	decreased fetal size	J:89751
	decreased heart left ventricle weight	J:110900
	decreased heart weight	J:110900
	decreased incidence of induced tumors	J:74001
	decreased incidence of tumors by chemical induction	J:96945
	decreased left ventricle developed pressure	J:110900
	decreased litter size	J:53600
	decreased locomotor activity	J:110900
	decreased myocardial fiber number	J:110900
	decreased spleen B cell follicle number	J:60223
	decreased spleen germinal center number	J:60223
	decreased T cell proliferation	J:60223
	dilated cardiomyopathy	J:110900
	heart left ventricle hypertrophy	J:110900
	normal homeostasis/metabolism phenotype	J:96945
	increased apoptosis	J:120065
	increased B cell apoptosis	J:60223
	increased cardiomyocyte apoptosis	J:110900
	increased embryonic tissue cell apoptosis	J:53600
	increased left ventricle diastolic pressure	J:110900
	increased male germ cell apoptosis	J:89751, J:120065
	infertility	J:53600
	kyphosis	J:120065
	open neural tube	J:53600
	premature aging	J:120065
	premature death	J:110900
	prenatal lethality, incomplete penetrance	J:53600, J:89751
	reduced female fertility	J:89751
	testicular atrophy	J:120065
	weight loss	J:110900
Terctm1Rdp/Terctm1Rdp involves: FVB/N	abnormal spermatid morphology	J:98586
	abnormal telomere length	J:98586